First Niles Financial, Inc. (FNFI)
OTCMKTS · Delayed Price · Currency is USD
8.40
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Verve Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Interest Income on Loans | 6.46 | 6.31 | 5.7 | 3.67 | 3.02 | 3.07 | Upgrade |
Interest Income on Investments | 1.19 | 1.19 | 1.01 | 0.6 | 0.26 | 0.44 | Upgrade |
Total Interest Income | 7.65 | 7.5 | 6.71 | 4.27 | 3.28 | 3.5 | Upgrade |
Interest Paid on Deposits | 2.58 | 2.5 | 1.44 | 0.53 | 0.53 | 0.61 | Upgrade |
Interest Paid on Borrowings | 2 | 2 | 1.95 | 0.73 | 0.6 | 0.65 | Upgrade |
Total Interest Expense | 4.58 | 4.5 | 3.39 | 1.26 | 1.13 | 1.26 | Upgrade |
Net Interest Income | 3.07 | 3 | 3.32 | 3.01 | 2.15 | 2.24 | Upgrade |
Net Interest Income Growth (YoY) | -5.18% | -9.38% | 10.10% | 39.92% | -3.93% | 5.66% | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.21 | Upgrade |
Other Non-Interest Income | 0.53 | 0.09 | 0.08 | 0.08 | 0.1 | 0.09 | Upgrade |
Total Non-Interest Income | 5.44 | 5 | 3.61 | 4.08 | 3.51 | 0.21 | Upgrade |
Non-Interest Income Growth (YoY) | 56.55% | 38.52% | -11.66% | 16.40% | 1546.48% | -16.47% | Upgrade |
Revenues Before Loan Losses | 8.51 | 8 | 6.92 | 7.09 | 5.66 | 2.45 | Upgrade |
Provision for Loan Losses | -0.02 | -0.04 | 0.13 | 0.02 | 0.02 | 0.15 | Upgrade |
| 8.53 | 8.04 | 6.8 | 7.07 | 5.64 | 2.3 | Upgrade | |
Revenue Growth (YoY) | 27.46% | 18.33% | -3.92% | 25.43% | 145.28% | -2.46% | Upgrade |
Salaries and Employee Benefits | 4.91 | 4.91 | 3.87 | 4.91 | 3.59 | 1.04 | Upgrade |
Occupancy Expenses | 0.16 | 0.16 | 0.41 | 0.39 | 0.19 | 0.09 | Upgrade |
Federal Deposit Insurance | 0.11 | 0.11 | 0.11 | 0.04 | 0.03 | 0.02 | Upgrade |
Selling, General & Administrative | 0.27 | 0.27 | 0.1 | 0.08 | 0.08 | 0.08 | Upgrade |
Other Non-Interest Expense | 1.95 | 1.44 | 1.3 | 1.21 | 1.04 | 0.69 | Upgrade |
Total Non-Interest Expense | 7.39 | 6.89 | 5.79 | 6.64 | 4.92 | 1.94 | Upgrade |
EBT Excluding Unusual Items | 1.14 | 1.16 | 1 | 0.44 | 0.72 | 0.36 | Upgrade |
Pretax Income | 1.14 | 1.16 | 1 | 0.44 | 0.72 | 0.36 | Upgrade |
Income Tax Expense | 0.3 | 0.29 | 0.19 | 0.19 | 0.13 | 0.05 | Upgrade |
Net Income | 0.84 | 0.86 | 0.81 | 0.25 | 0.59 | 0.3 | Upgrade |
Net Income to Common | 0.84 | 0.86 | 0.81 | 0.25 | 0.59 | 0.3 | Upgrade |
Net Income Growth | 6.57% | 6.81% | 220.63% | -57.00% | 94.04% | -28.94% | Upgrade |
Basic Shares Outstanding | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
Diluted Shares Outstanding | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
Shares Change (YoY) | 1.54% | - | - | 10.66% | 8.23% | - | Upgrade |
EPS (Basic) | 0.62 | 0.65 | 0.61 | 0.19 | 0.49 | 0.27 | Upgrade |
EPS (Diluted) | 0.61 | 0.64 | 0.60 | 0.18 | 0.48 | 0.27 | Upgrade |
EPS Growth | 4.82% | 6.67% | 233.33% | -62.50% | 77.78% | -28.95% | Upgrade |
Dividend Per Share | - | 0.240 | 0.240 | 0.240 | 0.240 | 0.240 | Upgrade |
Dividend Growth | - | - | - | - | - | 14.29% | Upgrade |
Effective Tax Rate | 25.92% | 25.28% | 19.36% | 42.47% | 18.38% | 15.17% | Upgrade |
Updated Feb 18, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.